The 2015 Annual meeting of the American Association of Pharmaceutical Scientists took place October 25-29 at the Orange County Convention Center in Orlando, FL. Attendance numbers for the meeting were not released, but the exposition hall was noticeably smaller than at past meetings, and the smaller crowd was the subject of numerous conversations. 
Fewer OINDP-focused vendors were exhibiting this year. Among those with booths were 3M Drug Delivery Systems and NGI maker MSP Corporation. Gateway Analytical, which provides services for nasal spray analysis was on hand, as were DPI capsule makers Qualicaps, which held a 90-minute seminar on “Advantages and Disadvantages of Various Inhaler Device Types,” and Capsugel.
Contract research and manufacturing companies offering services for OINDPs at the meeting included PPD, Quotient Clinical, Irvine Pharmaceutical Services, CEPIA (Sanofi), Cirrus Pharmaceuticals, MedPharm, and Juniper Pharmaceutical Services (formerly Molecular Profiles).
Other companies offering services and products to OINDP developers included Lubrizol, which in addition to offering excipients for nasal sprays, recently acquired CDMO Particle Sciences; Freeman Technology and Mercury Scientific, both offering instruments for powder flow analysis; inhalation lactose supplier DFE Pharma; and GenSyn Technologies, a particle engineering company that has worked on several dry powder formulations for inhalation.
Several OINDP specialists also expressed interest in equipment displayed by a company called Thinky, especially the NP-100 Nano Pulverizer which can pulverize amounts as small as 10 mg with cooling down to -20 °C in as little as 2 minutes.
Despite the small numbers of attendees looking at exhibits, approximately 75 people attended the Inhalation and Nasal Technology Focus Group (INTFG) annual membership meeting, which featured a talk by Next Breath President Julie Suman on nose to brain drug delivery. At least 50 focus group members were in attendance and participated in the group’s annual election.
Philip Kuehl of the Lovelace Respiratory Research Institute ran unopposed for the INTFG Vice Chair Position, and Benjamin Maynor of Liquidia ran unopposed for the Secretary Position. Peter Mack of Pearl Therapeutics and Samiran De of Lupin were elected as general members of the executive committee, and Mandana Azimi of Virginia Commonwealth University won the election for student member.
